Several mechanisms were proposed to be involved in ATX upregulation in the context of diet-induced obesity and metabolic disease, including inflammation, high glucose, and insulin (Figure 1). The gene discussed is ENPP2; the disease is obesity due to melanocortin 4 receptor deficiency.